Cargando…

Dysglycemia in young women attenuates the protective effect against fatty liver disease

INTRODUCTION: Sexual dimorphism has been reported in non-alcoholic fatty liver disease (NAFLD), similar to the sex differences evident with cardiovascular disease. Type 2 diabetes mellitus (T2D) significantly increases the risk and severity of NAFLD, but there is scarce information on whether T2D or...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez-Montes de Oca, Alejandra, Julián, María Teresa, Pera, Guillem, Caballería, Llorenç, Morillas, Rosa, Torán, Pere, Expósito, Carmen, Franch-Nadal, Josep, Mauricio, Didac, Alonso, Nuria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720265/
https://www.ncbi.nlm.nih.gov/pubmed/36479218
http://dx.doi.org/10.3389/fendo.2022.971864
_version_ 1784843518250844160
author Pérez-Montes de Oca, Alejandra
Julián, María Teresa
Pera, Guillem
Caballería, Llorenç
Morillas, Rosa
Torán, Pere
Expósito, Carmen
Franch-Nadal, Josep
Mauricio, Didac
Alonso, Nuria
author_facet Pérez-Montes de Oca, Alejandra
Julián, María Teresa
Pera, Guillem
Caballería, Llorenç
Morillas, Rosa
Torán, Pere
Expósito, Carmen
Franch-Nadal, Josep
Mauricio, Didac
Alonso, Nuria
author_sort Pérez-Montes de Oca, Alejandra
collection PubMed
description INTRODUCTION: Sexual dimorphism has been reported in non-alcoholic fatty liver disease (NAFLD), similar to the sex differences evident with cardiovascular disease. Type 2 diabetes mellitus (T2D) significantly increases the risk and severity of NAFLD, but there is scarce information on whether T2D or altered glucose metabolism can modify the prevalence of NAFLD in men and women of reproductive age. PURPOSE: To investigate the relationship between age, sex and NAFLD in subjects with and without dysglycemia. MATERIALS AND METHODS: We analyzed 2,790 patients. NAFLD was characterized using established diagnostic criteria: one or more positive results on the fatty liver index and hepatic ultrasound. Liver fibrosis (liver stiffness measurement [LSM] ≥8.0 kPa) was assessed by Fibroscan(®). For analysis purposes, we included both T2D and prediabetes under the predefined condition of dysglycemia. RESULTS: The global prevalence of NAFLD was higher in men than in women (50% and 34%; P<0.001), and the prevalence increased with age in both sexes. Older women (≥ 50 years) had a higher prevalence than younger women (<50 years), both in the overall cohort and in non-dysglycemic subjects. In dysglycemic subjects, the prevalence of NAFLD was slightly higher in men (68% vs 61%, p=0.021); in younger subjects, there were no differences in the prevalence of NAFLD between men and women (68% vs 64%, respectively; p=0.635). We found an interaction between dysglycemia and female sex (odds ratio [OR] 1.6 95% confidence interval [CI] 1.0-2.4, p=0.030), and between and age ≥50 years (OR 0.6, 95% CI 0.3-1.0, p=0.046). The global prevalence of LSM ≥8.0 kPa was higher in men compared with women (8% vs 4%; p< 0.001). This prevalence increased with age, mainly in men. We did not find any association between liver fibrosis and age and gender. CONCLUSIONS: While the global prevalence of NAFLD is higher in men than in women across all ages, younger women with dysglycemia have a similar risk of developing NAFLD as men of a similar age. Therefore, the presence of dysglycemia may erase the protective effect of female sex against fatty liver disease.
format Online
Article
Text
id pubmed-9720265
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97202652022-12-06 Dysglycemia in young women attenuates the protective effect against fatty liver disease Pérez-Montes de Oca, Alejandra Julián, María Teresa Pera, Guillem Caballería, Llorenç Morillas, Rosa Torán, Pere Expósito, Carmen Franch-Nadal, Josep Mauricio, Didac Alonso, Nuria Front Endocrinol (Lausanne) Endocrinology INTRODUCTION: Sexual dimorphism has been reported in non-alcoholic fatty liver disease (NAFLD), similar to the sex differences evident with cardiovascular disease. Type 2 diabetes mellitus (T2D) significantly increases the risk and severity of NAFLD, but there is scarce information on whether T2D or altered glucose metabolism can modify the prevalence of NAFLD in men and women of reproductive age. PURPOSE: To investigate the relationship between age, sex and NAFLD in subjects with and without dysglycemia. MATERIALS AND METHODS: We analyzed 2,790 patients. NAFLD was characterized using established diagnostic criteria: one or more positive results on the fatty liver index and hepatic ultrasound. Liver fibrosis (liver stiffness measurement [LSM] ≥8.0 kPa) was assessed by Fibroscan(®). For analysis purposes, we included both T2D and prediabetes under the predefined condition of dysglycemia. RESULTS: The global prevalence of NAFLD was higher in men than in women (50% and 34%; P<0.001), and the prevalence increased with age in both sexes. Older women (≥ 50 years) had a higher prevalence than younger women (<50 years), both in the overall cohort and in non-dysglycemic subjects. In dysglycemic subjects, the prevalence of NAFLD was slightly higher in men (68% vs 61%, p=0.021); in younger subjects, there were no differences in the prevalence of NAFLD between men and women (68% vs 64%, respectively; p=0.635). We found an interaction between dysglycemia and female sex (odds ratio [OR] 1.6 95% confidence interval [CI] 1.0-2.4, p=0.030), and between and age ≥50 years (OR 0.6, 95% CI 0.3-1.0, p=0.046). The global prevalence of LSM ≥8.0 kPa was higher in men compared with women (8% vs 4%; p< 0.001). This prevalence increased with age, mainly in men. We did not find any association between liver fibrosis and age and gender. CONCLUSIONS: While the global prevalence of NAFLD is higher in men than in women across all ages, younger women with dysglycemia have a similar risk of developing NAFLD as men of a similar age. Therefore, the presence of dysglycemia may erase the protective effect of female sex against fatty liver disease. Frontiers Media S.A. 2022-11-21 /pmc/articles/PMC9720265/ /pubmed/36479218 http://dx.doi.org/10.3389/fendo.2022.971864 Text en Copyright © 2022 Pérez-Montes de Oca, Julián, Pera, Caballería, Morillas, Torán, Expósito, Franch-Nadal, Mauricio and Alonso https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Pérez-Montes de Oca, Alejandra
Julián, María Teresa
Pera, Guillem
Caballería, Llorenç
Morillas, Rosa
Torán, Pere
Expósito, Carmen
Franch-Nadal, Josep
Mauricio, Didac
Alonso, Nuria
Dysglycemia in young women attenuates the protective effect against fatty liver disease
title Dysglycemia in young women attenuates the protective effect against fatty liver disease
title_full Dysglycemia in young women attenuates the protective effect against fatty liver disease
title_fullStr Dysglycemia in young women attenuates the protective effect against fatty liver disease
title_full_unstemmed Dysglycemia in young women attenuates the protective effect against fatty liver disease
title_short Dysglycemia in young women attenuates the protective effect against fatty liver disease
title_sort dysglycemia in young women attenuates the protective effect against fatty liver disease
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720265/
https://www.ncbi.nlm.nih.gov/pubmed/36479218
http://dx.doi.org/10.3389/fendo.2022.971864
work_keys_str_mv AT perezmontesdeocaalejandra dysglycemiainyoungwomenattenuatestheprotectiveeffectagainstfattyliverdisease
AT julianmariateresa dysglycemiainyoungwomenattenuatestheprotectiveeffectagainstfattyliverdisease
AT peraguillem dysglycemiainyoungwomenattenuatestheprotectiveeffectagainstfattyliverdisease
AT caballeriallorenc dysglycemiainyoungwomenattenuatestheprotectiveeffectagainstfattyliverdisease
AT morillasrosa dysglycemiainyoungwomenattenuatestheprotectiveeffectagainstfattyliverdisease
AT toranpere dysglycemiainyoungwomenattenuatestheprotectiveeffectagainstfattyliverdisease
AT expositocarmen dysglycemiainyoungwomenattenuatestheprotectiveeffectagainstfattyliverdisease
AT franchnadaljosep dysglycemiainyoungwomenattenuatestheprotectiveeffectagainstfattyliverdisease
AT mauriciodidac dysglycemiainyoungwomenattenuatestheprotectiveeffectagainstfattyliverdisease
AT alonsonuria dysglycemiainyoungwomenattenuatestheprotectiveeffectagainstfattyliverdisease